Skip to content

Validation of a Vital Signs Monitoring Wristband

Multi Parameter Vital Signs Monitoring by the Corsano CardioWatch 287-2 Validation Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05566886
Acronym
MULTI-VITAL
Enrollment
100
Registered
2022-10-04
Start date
2022-10-19
Completion date
2023-02-07
Last updated
2025-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

Vital signs, Blood pressure, Oxygen saturation, Heart rate, Respiratory rate

Brief summary

Today, continuous monitoring of vital signs remains a challenge since it generally requires the patient to be connected to multiple wired sensors, which restricts patient mobility in the intra-mural setting and complicates home monitoring in the extra-mural setting. Wearable devices on the wrist, although emerging, are often not clinically validated or limited to the monitoring of one or two vital signs. This study aims to validate the Corsano CardioWatch 287-2 for the continuous monitoring of heart rate at ≤ 4 bpm root mean squared error (RMSE); interbeat intervals at ≤ 50 ms RMSE; breathing rate at ≤ 2 brpm RMSE; and peripheral oxygen saturation at ≤ 3 percentage point RMSE. Also, this study aims to validate the Corsano CardioWatch 287-2 for the measurement of non-invasive blood pressure according to ISO 81060-2:2018.

Interventions

DEVICEContinuous measurement of photoplethysmography at the wrist

Patients receive a wristband that uses multi-color LEDs to measure pulsations at the wrist.

Sponsors

Corsano Health B.V.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* 18 years old; * undergoing invasive monitoring, like coronary angiography; * able to provide consent.

Exclusion criteria

Patients * who cannot wear the Corsano CardioWatch 287 due to reasons such as allergic reactions, wounds, amputations etc.; * unable or not willing to sign informed consent; * with significant mental or cognitive impairment; * who do not have a suitable entry site for the invasive arterial line * who do not comply to criteria established by ISO 81060-2:2018.

Design outcomes

Primary

MeasureTime frameDescription
RMSE of Heart Rate30 minutesRoot-mean-squared error between PPG measured and gold standard measured heart rate
RMSE of Respiratory Rate30 minutesRoot-mean-squared error between PPG measured and gold standard measured respiratory rate
RMSE of Oxygen Saturation30 minutesRoot-mean-squared error between PPG measured and gold standard measured oxygen saturation
RMSE of Blood Pressure30 minutesRoot-mean-squared error between PPG measured and gold standard measured blood pressure (systolic blood pressure and diastolic blood pressure)

Countries

Netherlands

Participant flow

Pre-assignment details

124 subjects undergoing heart catheterization were screened. 24 participants were not included due to: * Lateral difference exceeding limits (n=8) * Arm circumference not within range (n=1) * Atrial fibrillation or arrhythmia (n=5) * Peripheral artery disease (n=3) * Unforeseen difficulties during procedure (n=2) * Other medical reasons (e.g., isolation for infection) (n=1) * Technical difficulties (measurement not started) (n=1) * Procedure canceled or postponed (n=3)

Participants by arm

ArmCount
Main Study Group
Subjects undergoing heart catheterization as standard of care.
100
Total100

Baseline characteristics

CharacteristicMain Study Group
Age, Continuous67.4 years
STANDARD_DEVIATION 11.1
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
33 Participants
Sex: Female, Male
Male
67 Participants
Skin colour (Fitzpatrick)
Fitzpatrick Class I-II
81 Participants
Skin colour (Fitzpatrick)
Fitzpatrick Class III-IV
16 Participants
Skin colour (Fitzpatrick)
Fitzpatrick Class V-VI
3 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 100
other
Total, other adverse events
0 / 100
serious
Total, serious adverse events
0 / 100

Outcome results

Primary

RMSE of Blood Pressure

Root-mean-squared error between PPG measured and gold standard measured blood pressure (systolic blood pressure and diastolic blood pressure)

Time frame: 30 minutes

Population: 100 subjects were included, however, 3 individuals did not meet pre-specified dampening criteria~As a result data of 97 patients and 420 measurement pairs was included in the analysis.

ArmMeasureGroupValue (MEAN)Dispersion
Main Study GroupRMSE of Blood PressureSystolic Blood Pressure3.7 mmHgStandard Deviation 4.4
Main Study GroupRMSE of Blood PressureDiastolic Blood Pressure2.5 mmHgStandard Deviation 3.7
Primary

RMSE of Heart Rate

Root-mean-squared error between PPG measured and gold standard measured heart rate

Time frame: 30 minutes

ArmMeasureValue (MEAN)
Main Study GroupRMSE of Heart Rate1.3 beats per minute
Primary

RMSE of Oxygen Saturation

Root-mean-squared error between PPG measured and gold standard measured oxygen saturation

Time frame: 30 minutes

ArmMeasureValue (MEAN)
Main Study GroupRMSE of Oxygen Saturation1.6 % of SpO2
Primary

RMSE of Respiratory Rate

Root-mean-squared error between PPG measured and gold standard measured respiratory rate

Time frame: 30 minutes

ArmMeasureValue (MEAN)
Main Study GroupRMSE of Respiratory Rate0.9 breaths per minute

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026